Evidence map›Paper›PMID 30271878›Full record

ArticlemSystems

Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality.

Sara R Selitsky, David Marron, Lisle E Mose, Joel S Parker, Dirk P Dittmer

Open access · goldAbstract read
In one paragraph

Article in mSystems. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Alternative tumour-specific antigens.Nature reviews. Cancer · 2019
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sara R SelitskyLineberger Comprehensive Cancer Center, School of Medicine at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
David MarronLineberger Comprehensive Cancer Center, School of Medicine at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Lisle E MoseLineberger Comprehensive Cancer Center, School of Medicine at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Joel S ParkerLineberger Comprehensive Cancer Center, School of Medicine at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Dirk P DittmerLineberger Comprehensive Cancer Center, School of Medicine at the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0003-4968-5656
University of North Carolina at Chapel Hill · US

Funding

Vironomics and Biostatistics CoreP01CA019014 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLOSSOM A DAMANIA, NANCY JOAN RAAB-TRAUB · 1985 to 2026
$43.8M
ART Modulation of Viral Pathogenesis in Oral EpitheliaR01DE018304 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2007 to 2025
$6.9M
NCI NIH HHS P01 CA019014NIDCR NIH HHS R01 DE018304
6 · The paper itself

Abstract

Epstein-Barr virus (EBV) is convincingly associated with gastric cancer, nasopharyngeal carcinoma, and certain lymphomas, but its role in other cancer types remains controversial. To test the hypothesis that there are additional cancer types with high prevalence of EBV, we determined EBV viral expression in all the Cancer Genome Atlas Project (TCGA) mRNA sequencing (mRNA-seq) samples (

Indexed as

B cellscancerEBVEpstein-Barr virusherpesvirusTCGAvirology

Identifiers

PMID30271878
PMCPMC6156273
OpenAlexW2892925460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.